Risk factors associated with perioperative myocardial damage in patients with severe aortic stenosis

Journal of Cardiovascular Surgery

Volumn 45, Issue 3, 2004, Pages 271-277

  Natsuaki, M ^a   Itoh, I ^a   Okazaki, Y ^a   Rikitake, K ^a   Ohtubo, S ^a   Furukawa, K ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Aortic valve, surgery; Cardioplegia; Myocardial ischemia; Prostheses and implants

Indexed keywords

CREATINE KINASE MB; LACTATE DEHYDROGENASE; CREATINE KINASE;

ADULT; AGED; AORTA CLAMPING; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOPLEGIA; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE INJURY; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERIOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PREVALENCE; RISK ASSESSMENT; SURGICAL TECHNIQUE; TIME; AORTA VALVE STENOSIS; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; HEART ARREST; HEART FUNCTION TEST; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART VALVE REPLACEMENT; HEMODYNAMICS; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROBABILITY; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; COHORT STUDIES; CREATINE KINASE; FEMALE; HEART ARREST, INDUCED; HEART FUNCTION TESTS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS; PROBABILITY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 4043118378     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 2+-ATPase during progression of left ventricular hypertrophy. Am J Physiol 1997; 272:H2416-24.
2. Lazar HL, Zhang X, Rivers S, Bernard S, Shemin RJ. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg 1995;60:411-6.
3. Menasche P, Tronc F, Nguyen A, Veyssie L, Demirag M, Lariviere J et al. Retrograde warm blood cardioplegia preserves hypertrophied myocardium: a clinical study. Ann Thorac Surg 1994;57:1429-34.
4. Flameng WJ, Herijgers P, Dewilde S, Lesaffre E. Continuous retrograde blood cardioplegia is associated with lower hospital mortality after heart valve surgery. J Thorac Cardiovasc Surg 2003;125:121-5.
5. Aldea GS, Hou D, Fonger JD, Shemin RJ. Inhomogenous and complementary antegrade and retrograde delivery of cardioplegic solution in the absence of coronary artery obstruction. J Thorac Cardiovasc Surg 1994;107:499-504.
6. Steinberg JB, Doherty NE, Munfakh NA, Geffin GA, Titus JS, Hoaglin DC et al. Oxygenated cardioplegia: the metabolic and functional effects of glucose and insulin. Ann Thorac Surg 1991;51: 620-9.
7. Natsuaki M, Ishihara S, Ohteki H, Imamura E, Koyanagi H. Effect of temperature on the arrested heart exposed to a 4-hour ischemia during blood potassium cardioplegia. Eur Surg Res 1983;15: 241-8.
8. Bishop SP, Altschuld RA. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol 1970;218: 153-9.
9. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-8.
10. Gorlin R, Gorlin SG. Hydraulic formula for calculation of area of stenotic mitral valve, other cardiac valves and central circulatory shunts. Am Heart J 1952;41:1-29.
11. Dahlin L-G, Kågedal B, Nylander E, Olin C, Rutberg H, Svedjeholm R. Early identification of permanent myocardial damage after coronary surgery is aided by repeated measurements of CK-MB. Scand Cardiovasc J 2002;36:35-40.
12. Aldea GS, Austin RE Jr, Flynn AE, Coggins DL, Husseini W, Hoffman JI. Heterogeous delivery of cardioplegic solution in the absence of coronary artery disease. J Thorac Cardiovasc Surg 1990;99: 345-53.
13. Partingon MT, Acar C, Buckberg GD, Julia PL. Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium. J Thorac Cardiovasc Surg 1989;97:613-22.
14. Stirling MC, McClanahan TB, Schott RJ, Lynch MJ, Bolling SF, Kirsh MM et al. Distribution of cardioplegic solution infused antegradely and retrogradely in normal canine hearts. J Thorac Cardiovasc Surg 1989;98:1066-76.
15. Cooke GA, Harris LJ, Grossi EA, Baumann FG, Gallaway AC, Colvin SB. Biventricular distribution of cold blood cardioplegia solution determined by different retrograde techniques. J Thorac Cardiovasc Surg 1991;102:631-8.
16. Gundry SR, Wang N, Sciolaro CM, Van Arsdell GS, Razzouk AJ, Hill AC et al. Uniformity of perfusion in all regions of the human heart by warm continuous retrograde cardioplegia. Ann Thorac Surg 1996;61:33-5.
17. Kulshrestha P, Rousou JA, Engelman RM, Flack JE 3rd, Deaton DW, Wait RB et al. Does warm blood retrograde cardioplegia preserve right ventricular function? Ann Thorac Surg 2001;72: 1572-5.
18. Buckberg GD, Drinkwater DC, Laks H. A new technique for delivering antegrade/retrograde blood cardioplegia without right heart isolation. Eur J Cardiothorac Surg 1990;4:163-8.
19. Friehs I, Moran AM, Stamm C, Colan SD, Takeuchi K, Cao-Danh H et al. Impaired glucose transporter activity in pressure-overload hypertrophy is an early indicator of progression to failure. Circulation 1999;100:II-187-93.
20. Takeuchi K, Buenaventura P, Cao-Danh H, Glynn P, Simplaceanu E, McGowan FX et al. Improved protection of the hypertrophied left ventricle by histidine-containing cardioplegia. Circulation 1995;92(9 Suppl):II395-9.
21. Hearse DJ, Stewart DA, Braimbridge MV. Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates. J Thorac Cardiovasc Surg 1978;76:16-23.
22. Gaasch WH, Zile MR, Hoshino PK, Weinberg EO, Rhodes DR, Apstein CS. Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy. Circulation 1990;81:1644-53.
23. Lund O, Flo C, Jensen FT, Emmertsen K, Nielsen TT, Rasmussen BS et al. Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms. Eur Heart J 1997;18:1977-87.
24. Orsinelli DA, Aurigemma GP, Battista S, Krendel S, Gaasch WH. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol 1993;22:1679-83.
25. Mehta RH, Bruckman D, Das S, Tsai T, Russman P, Karavite D et al. Implications of increased left ventricular mass index on inhospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 2001;22:919-28.